Concepedia

The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients

Angelo Antonini, Giovanni Abbruzzese, Alfredo Berardelli, Nicola Modugno, Italo Stroppa, Filippo Tamma, Mariachiara Sensi, Francesca Mancini, Giovanni Cossu, Nicola Tambasco,

Journal of Neural Transmission · 2020 · 16 citations · 26 references

DOI

Concepts

References

26

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 696 citations

, , +12

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach

Angelo Antonini, A. Jon Stoessl, Leah Kleinman et al. · Current Medical Research and Opinion · 2018 · 264 citations · Full text

, , +14

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 239 citations · Full text

, , +14

Optimizing Levodopa Pharmacokinetics: Intestinal Infusion Versus Oral Sustained-Release Tablets

Dag Nyholm, Håkan Askmark, Cecilia Gomes–Trolin et al. · Clinical Neuropharmacology · 2003 · 237 citations

, , +16

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Angelo Antonini, Werner Poewe, К. Ray Chaudhuri et al. · Parkinsonism & Related Disorders · 2017 · 210 citations · Full text

, , +15